SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 43.03 |
| Enterprise Value ($M) | 31.89 |
| Book Value ($M) | 156.43 |
| Book Value / Share | 3.71 |
| Price / Book | 0.28 |
| NCAV ($M) | 115.60 |
| NCAV / Share | 2.74 |
| Price / NCAV | 0.37 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.75 |
| Return on Assets (ROA) | -0.47 |
| Return on Equity (ROE) | -0.55 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.04 |
| Current Ratio | 7.04 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 156.39 |
| Assets | 197.22 |
| Liabilities | 40.79 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Ubs Asset Management Americas Inc | 0.00 | -100.00 | |
| 13G/A | Vaddi Krishna | 11.10 | 14.16 | |
| 13G/A | Flynn James E | 9.85 | 28.25 | |
| 13G/A | Fmr Llc | 0.63 | -94.57 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 17,643 | 79,905 | 22.08 | |
| 25,435 | 130,440 | 19.50 | |
| 82,758 | 389,353 | 21.26 | |
| 92,431 | 318,965 | 28.98 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PLRX – Pliant Therapeutics, Inc. | PMVP – PMV Pharmaceuticals, Inc. |
| PRAX – Praxis Precision Medicines, Inc. | PRTA – Prothena Corporation plc |
| PTCT – PTC Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io